Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2026)
Cytek Biosciences (CTKB) posted Income towards Parent Company of -$18.9 million for Q1 2026, up 57.14% on a QoQ basis from -$44.0 million in Q4 2025, and down 65.52% year-over-year from -$54.7 million in Q1 2025.
Cytek Biosciences (CTKB) Income towards Parent Company (2020 - 2026) Analysis & Trends
Cytek Biosciences' Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$18.9 million for Q1 2026.
- Quarterly Income towards Parent Company fell 65.52% year-over-year to -$18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$74.0 million (down 555.85% YoY) and the FY2025 annual result came in at -$66.5 million, down 1005.3% from the prior year.
- Income towards Parent Company was -$18.9 million for Q1 2026 at Cytek Biosciences, up from -$44.0 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $9.6 million in Q4 2024 and bottomed at -$44.0 million in Q4 2025.
- A 5-year average of -$5.9 million and a median of -$5.5 million in 2025 frame the typical range for Income towards Parent Company.
- Peak annual rise in Income towards Parent Company reached 419.14% in 2022, while the deepest fall reached 2215.69% in 2022.
- Cytek Biosciences' Income towards Parent Company stood at $3.7 million in 2022, then jumped by 48.01% to $5.5 million in 2023, then soared by 74.5% to $9.6 million in 2024, then plunged by 558.49% to -$44.0 million in 2025, then surged by 57.14% to -$18.9 million in 2026.
- Business Quant data shows CTKB's Income towards Parent Company at -$18.9 million in Q1 2026, -$44.0 million in Q4 2025, and -$5.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -44.03 Mn |
| Sep 30, 2025 | -5.47 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 957,000.00 |
| Jun 30, 2024 | -10.43 Mn |
| Mar 31, 2024 | -6.19 Mn |
| Dec 31, 2023 | 5.50 Mn |
| Sep 30, 2023 | -6.46 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -6.84 Mn |
| Dec 31, 2022 | 3.72 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -702,000.00 |
| Mar 31, 2022 | -2.16 Mn |
| Dec 31, 2021 | -1.17 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 2.67 Mn |